Skip to content

Safety and feasibility of indwelling pigtail catheter after thoracoscopic anatomical lung resection: a single-center randomized controlled trial

Safety and feasibility of indwelling pigtail catheter after thoracoscopic anatomical lung resection: a single-center randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057490
Enrollment
Unknown
Registered
2022-03-14
Start date
2022-05-01
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer with early stage

Interventions

Group 1:Pigtail catheter
Group 2:24Fr chest tube

Sponsors

Shenzhen Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients voluntarily participate in clinical trials and have the responsibility and ability to sign informed consent. 2. Aged between 16-65 years. 3. Preoperative CT of the chest is considered as early lung cancer, which can be resectioned by lobes/segments, and lymph node sampling should be taken. 4. ECOG (Physical Status) score <=1 point. 5. ASA (Anaesthesia Score) <=2. 6. Cardiopulmonary function and other important organ functions are basically normal and can tolerate surgery.

Exclusion criteria

Exclusion criteria: 1. Previous surgery on the same side of the thoracic cavity or lung and other reasons have caused severe adhesions in the thoracic cavity. 2. Open thoracotomy or switch to thoracotomy during operation. 3. Diffuse emphysema. 4. Systemic lymph node dissection is required according to the condition. 5. Those who are allergic to penicillin, cephalosporin, morphine or the drugs involved in the program.

Design outcomes

Primary

MeasureTime frame
Re-indwelling chest tube rate after extubation;

Secondary

MeasureTime frame
Visual analogue scale score;Postoperative complications;Rehospitalization rate;

Countries

China

Contacts

Public ContactZheng Shuo

Shenzhen Third People's Hospital

xwkpdz@163.com+86 13120121233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026